Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel
- Author
- HANATANI, T1 2 ; SAI, K1 ; KAWAKAMI, J7 ; SAITO, Y1 ; TOHKIN, M2 ; SEGAWA, K1 ; ANTOKU, Y3 ; NAKASHIMA, N3 ; YOKOI, H4 ; OHE, K5 ; KIMURA, M6 ; HORI, K7
[1] Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan
[2] Department of Regulatory Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Aichi, Japan
[3] Medical Information Center, Kyushu University Hospital, Fukuoka, Japan
[4] Department of Medical Informatics, Kagawa University Hospital, Kagawa, Japan
[5] Department of Medical Informatics and Economics, Division of Social Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
[6] Department of Medical Informatics, Hamamatsu University School of Medicine, Shizuoka, Japan
[7] Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Shizuoka, Japan - Source
Journal of clinical pharmacy and therapeutics (Print). 2014, Vol 39, Num 4, pp 361-367, 7 p ; ref : 37 ref
- ISSN
- 0269-4727
- Scientific domain
- Pharmacology drugs
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- clopidogrel medical information database omeprazole oseltamivir pharmacovigilance regulatory action
- Keyword (fr)
- Adolescent Antisécrétoire Antithrombotique Antiulcéreux Antiviral Base de données Clopidogrel Evaluation Information thérapeutique Information Inhibiteur thromboagrégation Interaction médicamenteuse Oméprazole Oséltamivir Pharmacovigilance Réglementation Utilisation Japon Dérivé de la thiénopyridine Dérivé du benzimidazole Enzyme Exo-α-sialidase Glycosidases Glycosylases H+/K+-exchanging ATPase Homme Hydrolases Inhibiteur enzyme Inhibiteur neuraminidase Inhibiteur pompe proton Asie
- Keyword (en)
- Adolescent Antisecretory agent Antithrombotic agent Antiulcer agent Antiviral Database Clopidogrel Evaluation Therapeutic information Information Antiplatelet agent Drug interaction Omeprazole Oseltamivir Pharmacovigilance Regulation Use Japan Thienopyridine derivative Benzimidazole derivatives Enzyme Exo-α-sialidase Glycosidases Glycosylases H+/K+-exchanging ATPase Human Hydrolases Enzyme inhibitor Neuraminidase inhibitor Proton pump inhibitor Asia
- Keyword (es)
- Adolescente Antisecretorio antitrombōtico Antiulceroso Antiviral Base dato Clopidogrel Evaluación Información terapéutica Información Inhibidor tromboagregación Interacción medicamentosa Omeprazol Oseltamivir Farmacovigilancia Reglamentación Uso Japón Tienopiridina derivado Benzimidazol derivado Enzima Exo-α-sialidase Glycosidases Glycosylases H+/K+-exchanging ATPase Hombre Hydrolases Inhibidor enzima Inhibidor neuraminidas Inhibidor bomba protón Asia
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02A General pharmacology / 002B02A07 Miscellaneous
- Discipline
- General pharmacology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28595142
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/jcpt.12153 
https://dx.doi.org/10.1111/jcpt.12153
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1111\/jcpt.12153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:53:\"Journal of clinical pharmacy and therapeutics (Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. clin. pharm. ther. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"361\";s:8:\"\u0000*\u0000epage\";s:3:\"367\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-4727\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"HANATANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"SAI, K\";i:1;s:11:\"KAWAKAMI, J\";i:2;s:8:\"SAITO, Y\";i:3;s:9:\"TOHKIN, M\";i:4;s:9:\"SEGAWA, K\";i:5;s:9:\"ANTOKU, Y\";i:6;s:12:\"NAKASHIMA, N\";i:7;s:8:\"YOKOI, H\";i:8;s:6:\"OHE, K\";i:9;s:9:\"KIMURA, M\";i:10;s:7:\"HORI, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1111\/jcpt.12153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:53:\"Journal of clinical pharmacy and therapeutics (Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. clin. pharm. ther. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"361\";s:8:\"\u0000*\u0000epage\";s:3:\"367\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-4727\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"HANATANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"SAI, K\";i:1;s:11:\"KAWAKAMI, J\";i:2;s:8:\"SAITO, Y\";i:3;s:9:\"TOHKIN, M\";i:4;s:9:\"SEGAWA, K\";i:5;s:9:\"ANTOKU, Y\";i:6;s:12:\"NAKASHIMA, N\";i:7;s:8:\"YOKOI, H\";i:8;s:6:\"OHE, K\";i:9;s:9:\"KIMURA, M\";i:10;s:7:\"HORI, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:18:\"10.1111\/jcpt.12153\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1111\/jcpt.12153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:53:\"Journal of clinical pharmacy and therapeutics (Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. clin. pharm. ther. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"361\";s:8:\"\u0000*\u0000epage\";s:3:\"367\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-4727\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"HANATANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"SAI, K\";i:1;s:11:\"KAWAKAMI, J\";i:2;s:8:\"SAITO, Y\";i:3;s:9:\"TOHKIN, M\";i:4;s:9:\"SEGAWA, K\";i:5;s:9:\"ANTOKU, Y\";i:6;s:12:\"NAKASHIMA, N\";i:7;s:8:\"YOKOI, H\";i:8;s:6:\"OHE, K\";i:9;s:9:\"KIMURA, M\";i:10;s:7:\"HORI, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1111\/jcpt.12153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:53:\"Journal of clinical pharmacy and therapeutics (Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. clin. pharm. ther. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"361\";s:8:\"\u0000*\u0000epage\";s:3:\"367\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-4727\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"HANATANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"SAI, K\";i:1;s:11:\"KAWAKAMI, J\";i:2;s:8:\"SAITO, Y\";i:3;s:9:\"TOHKIN, M\";i:4;s:9:\"SEGAWA, K\";i:5;s:9:\"ANTOKU, Y\";i:6;s:12:\"NAKASHIMA, N\";i:7;s:8:\"YOKOI, H\";i:8;s:6:\"OHE, K\";i:9;s:9:\"KIMURA, M\";i:10;s:7:\"HORI, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1111\/jcpt.12153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:53:\"Journal of clinical pharmacy and therapeutics (Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. clin. pharm. ther. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"361\";s:8:\"\u0000*\u0000epage\";s:3:\"367\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-4727\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"HANATANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"SAI, K\";i:1;s:11:\"KAWAKAMI, J\";i:2;s:8:\"SAITO, Y\";i:3;s:9:\"TOHKIN, M\";i:4;s:9:\"SEGAWA, K\";i:5;s:9:\"ANTOKU, Y\";i:6;s:12:\"NAKASHIMA, N\";i:7;s:8:\"YOKOI, H\";i:8;s:6:\"OHE, K\";i:9;s:9:\"KIMURA, M\";i:10;s:7:\"HORI, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:229:\"Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
